相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Simultaneous Knockdown of Immune Suppressive Markers by Tumor Microenvironment-Responsive Multifaceted Prodrug Nanomedicine
Liuwei Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2023)
Charge reversal yolk-shell liposome co-loaded JQ1 and doxorubicin with high drug loading and optimal ratio for synergistically enhanced tumor chemo-immunotherapy via blockade PD-L1 pathway
Dechun Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)
pH-responsive organic/inorganic hybrid nanocolloids for transcellular delivery of ribonucleolytic payloads toward targeted anti-glioma therapy
Hongyan Cui et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2023)
Enzyme-triggered deep tumor penetration of a dual-drug nanomedicine enables an enhanced cancer combination therapy
Lei Gu et al.
BIOACTIVE MATERIALS (2023)
GSH-sensitive polymeric prodrug: Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine
Lei Luo et al.
ACTA PHARMACEUTICA SINICA B (2022)
Impact of the amount of PEG on prodrug nanoassemblies for efficient cancer therapy
Yaqiao Li et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma
Hongyan Cui et al.
ACS APPLIED MATERIALS & INTERFACES (2022)
Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment
Jun Gu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Genetically Engineered Hematopoietic Stem Cells Deliver TGF-β Inhibitor to Enhance Bone Metastases Immunotherapy
Beilei Wang et al.
ADVANCED SCIENCE (2022)
Synthetic Nanoscale RNAi Constructs as Pesticides for the Control of Locust Migratoria
Qiong Lu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2022)
Protein Binding Nanoparticles as an Integrated Platform for Cancer Diagnosis and Treatment
Xuemei Wang et al.
ADVANCED SCIENCE (2022)
Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
Hyemin Ju et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy
Xiangru Feng et al.
SCIENCE BULLETIN (2021)
Recent advances in development of dendriticpolymer-basednanomedicines for cancer diagnosis
Haonan Li et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)
Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
Zhi-di He et al.
ACTA PHARMACOLOGICA SINICA (2021)
Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy
Liuwei Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Overcoming immune resistance by sequential prodrug nanovesicles for promoting chemoimmunotherapy of cancer
Fengqi Zhou et al.
NANO TODAY (2021)
Self-Stabilized Supramolecular Assemblies Constructed from PEGylated Dendritic Peptide Conjugate for Augmenting Tumor Retention and Therapy
Xiuli Zheng et al.
ADVANCED SCIENCE (2021)
A cellular census of human peripheral immune cells identifies novel cell states in lung diseases
Dongli Song et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming
Samantha M. Morrissey et al.
CELL METABOLISM (2021)
The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
Wenxiao Jiang et al.
MOLECULAR CANCER (2021)
Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulating HDAC1 in molecular subtypes of breast cancer
Amjad Ali et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
Tumor cells suppress radiation-induced immunity by hijacking caspase 9 signaling
Chuanhui Han et al.
NATURE IMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
Xiaoqing Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
JQ1, a BET-bromodomain inhibitor, inhibits human cancer growth and suppresses PD-L1 expression
Kaisheng Liu et al.
CELL BIOLOGY INTERNATIONAL (2019)
Reprogramming Tumor Immune Microenvironment (TIME) and Metabolism via Biomimetic Targeting Codelivery of Shikonin/JQ1
Hairui Wang et al.
NANO LETTERS (2019)
Bioinspired lipoproteins-mediated photothermia remodels tumor stroma to improve cancer cell accessibility of second nanoparticles
Tao Tan et al.
NATURE COMMUNICATIONS (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
Integument of Cytoplasmic Membrane onto Cationic DNA Condensates for Selective Gene Expression at Homologous Cells
Hongyan Cui et al.
ACS APPLIED BIO MATERIALS (2019)
A tumor microenvironment responsive biodegradable CaCO3/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy
Yanlei Liu et al.
THERANOSTICS (2019)
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Tingting Wang et al.
NATURE COMMUNICATIONS (2018)
Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles
Fred C. Lam et al.
NATURE COMMUNICATIONS (2018)
Progress and challenges towards targeted delivery of cancer therapeutics
Daniel Rosenblum et al.
NATURE COMMUNICATIONS (2018)
PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
Priya Srinivasan et al.
PLOS MEDICINE (2018)
Pod-Like Supramicelles with Multicompartment Hydrophobic Cores Prepared by Self-Assembly of Modified Chitosan
Yiming Wang et al.
NANO-MICRO LETTERS (2016)
Pod-Like Supramicelles with Multicompartment Hydrophobic Cores Prepared by Self-Assembly of Modified Chitosan
Yiming Wang et al.
NANO-MICRO LETTERS (2016)
Multifunctional organically modified silica nanoparticles for chemotherapy, adjuvant hyperthermia and near infrared imaging
Abhignyan Nagesetti et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Facile Fabrication of Tumor Redox-Sensitive Nanoassemblies of Small-Molecule Oleate Prodrug as Potent Chemotherapeutic Nanomedicine
Cong Luo et al.
SMALL (2016)
Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents
Olaf Klingbeil et al.
CELL DEATH & DISEASE (2016)
Hydrophosphination of CO2 and Subsequent Formate Transfer in the 1,3,2-Diazaphospholene-Catalyzed N-Formylation of Amines
Che Chang Chong et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Inhibition of Bromodomain Proteins for the Treatment of Human Diffuse Large B- cell Lymphoma
Sally E. Trabucco et al.
CLINICAL CANCER RESEARCH (2015)
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cells
Timothy J. Haggerty et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis
Ping Zhang et al.
MOLECULAR IMMUNOLOGY (2008)
Tumor cell death induced by topoisomerase-targeting drugs
TK Li et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2001)